Bio-Techne (TECH) Free Cash Flow Growth (1y) (2010 - 2026)
Bio-Techne (TECH) Free Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - | 7.12% |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.73 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | - |
| 4 | BeOne Medicines | 472.60 Bn | 467.81 Bn | 1.35 Bn | 1,092.51% |
| 5 | Vertex Pharmaceuticals | 122.34 Bn | 115.09 Bn | 2.59 Bn | 66.37% |
| 6 | Regeneron Pharmaceuticals | 70.14 Bn | 61.39 Bn | 3.31 Bn | 3.98% |
| 7 | Belite Bio | 62.79 Bn | 62.79 Bn | - | - |
| 8 | Argenx Se | 56.19 Bn | 51.00 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn | 137.65% |
| 10 | Bio-Techne | 11.21 Bn | 11.00 Bn | 208.29 Mn | 150.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 150.27% |
| Dec 31, 2025 | -1.34% |
| Sep 30, 2025 | -59.39% |
| Jun 30, 2025 | 62.23% |
| Mar 31, 2025 | -51.98% |
| Dec 31, 2024 | 13.59% |
| Sep 30, 2024 | 19.49% |
| Jun 30, 2024 | -20.74% |
| Mar 31, 2024 | 66.41% |
| Dec 31, 2023 | 17.12% |
| Sep 30, 2023 | -1.58% |
| Jun 30, 2023 | -18.60% |
| Mar 31, 2023 | -33.16% |
| Dec 31, 2022 | -35.84% |
| Sep 30, 2022 | 9.82% |
| Jun 30, 2022 | -19.47% |
| Mar 31, 2022 | -9.70% |
| Dec 31, 2021 | 16.71% |
| Sep 30, 2021 | -23.07% |
| Jun 30, 2021 | 303.76% |